Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2018 and based in Amsterdam, Curie Capital BV is a venture capital firm dedicated to the Life Sciences sector. The firm manages investments primarily in early-stage companies, particularly in biotechnology, pharmaceuticals, and medical technology. Curie Capital adheres to RVO seed capital regulations, investing in companies that have not raised more than €3.5 million in equity or convertible loans.
Curie Capital invests in Seed and Series A stage companies engaged in therapeutics, diagnostics, and class IIb and III medical devices. The firm emphasizes supporting talented teams developing innovative medical products through both capital and strategic guidance.
Curie Capital's portfolio includes notable companies such as Laigo Bio, which focuses on targeted protein degradation candidates in oncology and auto-immunity; AvidiCure, developing innovative medical solutions; TargED Biopharmaceuticals, a clinical-stage biotechnology company; Clearabiotech, specializing in biotechnological advancements; Sirius Medical, known for surgical marker navigation technologies; Allero Therapeutics, which develops therapies for allergic conditions; and Citryll, focusing on innovative diagnostic solutions.
Submit your pitch through their form at curiecapital.nl or email dealflow@curiecapital.nl with your deck.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.